- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Australian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
4
Mid-Large Cap Stocks
4 companies
CSL
Market Cap: AU$115.4b
Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$238.38
7D
-0.6%
1Y
-16.9%
Neuren Pharmaceuticals
Market Cap: AU$1.6b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$12.96
7D
1.3%
1Y
-40.6%
Mesoblast
Market Cap: AU$2.3b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$1.80
7D
3.2%
1Y
75.6%
Telix Pharmaceuticals
Market Cap: AU$8.5b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States.
TLX
AU$25.14
7D
-5.6%
1Y
62.7%